Daxor Corporation Announces Dr. Joseph Feldschuh, President and CEO, Sustained a Fractured Hip, Had Emergency Surgery, and Received a Transfusion of His Own Frozen Blood Which Had Been Stored Four Years Ago

NEW YORK, NY--(Marketwired - Feb 11, 2014) - Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announced that its President and Chief Executive Officer, Dr. Joseph Feldschuh, fractured his hip on February 4, 2014 when he slipped on black ice outside his house.

He was taken to Montefiore l Medical Center and emergency surgery was performed on the same day. Dr. Feldschuh has been on the staff of Montefiore for 53 years. The surgery involved the insertion of a special orthopedic nail, screw, and a plate to restore the integrity of the fractured femur. As a result of the surgery Dr. Feldschuh will retain the use of his own hip. 

Dr. Feldschuh's blood was thawed and shipped to the hospital on the day of his surgery from Daxor's facility in Manhattan. At the time, his surgeons expressed the belief that he was not likely to need any transfusions. The next day Dr. Feldschuh's physicians noted that he had persistent tachycardia which is a fast pulse. It seemed to be increasing over several hours. Dr. Feldschuh's one unit of stored frozen blood was administered with continuous monitoring over a one-hour period. His pulse gradually went back to normal as the blood transfusion was administered. Subsequent tests and changes in hematocrit (which measures the concentration of blood) demonstrated that Dr. Feldschuh has lost approximately 30% of the blood in his body. 

On February 10^th, Dr. Feldschuh was discharged to a specialized rehabilitation facility, the Hebrew Home at Riverdale. Dr. Feldschuh stated today, upon leaving Montefiore Medical Center, "I am grateful for the skilled surgical care I received. Over the years I had stored blood which expired unused. I never anticipated that one day I would be the beneficiary of this program."

Dr. Feldschuh is responsible for initiating the first autologous blood storage program in the US in 1987 after his father underwent successful abdominal surgery and contracted Hepatitis, which in many cases,causes death within 7 years. This FDA approved process allows for frozen red blood cells to be stored for up to 10 years.

Daxor provides a unique frozen blood storage program for individuals through its Idant Laboratories subsidiary, which allows them to store their own blood for up to ten years. This is a major advantage over refrigerated blood which can only be stored for up to 42 days. It has been proven that if someone needs a transfusion, the safest blood to use is their own. The freezing and restoring of blood requires highly specialized technology. 

For more information regarding Daxor's Blood Volume Analyzer BVA-100, visit the Company's website at www.Daxor.com.